Company announcement no. 10 - 2614 April 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG…
April 14, 2026 03:30 ET | Source: Asgard Therapeutics Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s…
ROSLYN, N.Y., April 13, 2026 (GLOBE NEWSWIRE) -- EmPRO Insurance Company (EmPRO), a licensed medical professional liability insurance carrier serving…
April 13, 2026 09:00 ET | Source: Senti Biosciences, Inc. SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) --…
BROOKLYN PARK, MN, April 13, 2026 (GLOBE NEWSWIRE) -- Switchback Medical, a medical device contract development and manufacturing organization (CDMO),…
Join the Grand Opening Celebration on May 1, 2026, for an Evening of Beauty and Innovation April 10, 2026 19:12…
Senior Vice President, Finance & Accounting John M. Gay named Chief Financial Officer April 10, 2026 17:00 ET | Source:…
April 10, 2026 16:09 ET | Source: Mesoblast Limited Working with Parent Project Muscular Dystrophy and the Duchenne Registry on…
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-treated…
Largo, FL, April 10, 2026 (GLOBE NEWSWIRE) -- A commission may be earned if you purchase through links in this…